Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.
| Author | |
|---|---|
| Year of Publication |
:
2018
|
| Journal |
:
Investigational new drugs
|
| Date Published |
:
2018
|
| ISSN Number |
:
0167-6997
|
| DOI |
:
10.1007/s10637-017-0558-5
|
| Short Title |
:
Invest New Drugs
|
| Download citation |
